Efavirenz versus boosted atazanavir-containing regimens and immunologic virologic and clinical outcomes

摘要

Objective:To compare regimens consisting of either ritonavir-boosted atazanavir or efavirenz and a nucleoside reverse transcriptase inhibitor (NRTI) backbone with respect to clinical, immunologic, and virologic outcomes.